
|Articles|October 1, 2005
Welcome to Ophthalmology Times Europe
I often feel that the European ophthalmology industry is becoming the victim of its own success. With the half-life value of ophthalmic knowledge on the continent now set at less than five years, compared with 30 years in 1960, innovation in Europe is not showing any signs of slowing down. Ophthalmologists in Europe are continuously required to update and broaden their specialist knowledge with the advent of new techniques, treatments, instruments and devices. With meetings every few weeks, around the globe, on all branches of ophthalmic science and clinical practice, how is it possible to keep up?
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
4
Port Delivery System Therapies in Retinal Vascular Diseases
5






















